Core Viewpoint - Metagenomi, Inc. is actively participating in the TD Cowen's 45th Annual Health Care Conference, showcasing its commitment to developing curative therapeutics through its proprietary gene editing toolbox [1]. Company Overview - Metagenomi is a precision genetic medicines company focused on curative therapeutics using an AI-driven metagenomics platform [3]. - The company leverages four billion years of microbial evolution to discover novel editing tools capable of correcting any genetic mutation in the genome [3]. - Its genome editing toolbox includes programmable nucleases, base editors, and RNA and DNA-mediated integration systems, such as prime editing systems and CAST [3]. - Metagenomi's proprietary toolbox is designed to access the entire genome and select optimal tools for effective genome editing [3]. Event Participation - Brian C. Thomas, PhD, CEO and founder of Metagenomi, will engage in a fireside chat at the conference on March 5, 2025, from 1:10-1:40 p.m. ET in Boston [1]. - The company will also host one-on-one investor meetings during the conference [1].
Metagenomi to Present at TD Cowen's 45th Annual Health Care Conference